Progyny Inc (NAS:PGNY)
$ 26.491 -0.509 (-1.89%) Market Cap: 2.52 Bil Enterprise Value: 2.22 Bil PE Ratio: 43.43 PB Ratio: 4.45 GF Score: 85/100

Progyny Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2022 / 01:15PM GMT
Release Date Price: $47.71 (+3.58%)
Anne Elizabeth Samuel
JPMorgan Chase & Co, Research Division - Analyst

Good morning, everyone, and welcome to day 2 of the JPMorgan Healthcare Conference. My name is Annie Samuel, and I am the health care technology and distribution analyst here at JPMorgan. We're thrilled to have with us this morning, Progyny. With us is CEO, Pete Anevski. And we're going to have them do a presentation and then following that, we'll do an interactive Q&A session. (Operator Instructions)

So with that, let me turn it over to Pete.

Peter Anevski
Progyny, Inc. - CEO

Thanks, Annie. Thanks, everybody, for joining us today. We appreciate the opportunity to present to you again this year during this very exciting time for Progyny.

Michael Sturmer, our President; and Mark Livingston, our CFO, are going to join me right after the presentation for Q&A. With that, let's get started.

I'll pause momentarily, so you can take note of the caution on Slide 2 regarding any forward-looking statements or non-GAAP financial measures that we may discuss

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot